Executive Insights I: Manufacturing and Supply - Lessons Learned from the Pandemic

Exclusive to DCAT Member Companies

Date/Time: Tuesday, July 13, 2021 - 10:00 AM to 11:00 AM EDT

About

Online registration for this program is now closed. To register over the phone, please contact Mikaela Venice at 1-609-208-1888 ext. 7015.

Current Registrants

Couldn't make the live webinar? No problem! Registrants now have access to on-demand viewing of this program until July 31, 2021. Click here to view the recording.

1-hr Webinar Featuring

  • Remo Colarusso, Vice President, Janssen Supply Chain, Johnson & Johnson 
  • Ken Kent, Senior Vice President, Chemical Development and Manufacturing Operations, Gilead Sciences

Program Highlights

  • J&J and Gilead Sciences: Their supply strategies for COVID-19 vaccines/treatments
  • Lessons learned for supply management: now and in the future
  • New collaborative models in supplier relationship management

Overview

In meeting the immense challenge of developing COVID-19 vaccines and treatments, Bio/Pharmaceutical companies have had to meet the equally substantial task of manufacturing and supplying large volumes of vaccines and treatments under accelerated timelines.

Hear from leading executives from Johnson & Johnson on its COVID-19 vaccine and Gilead Sciences for remdesivir, its small-molecule antiviral drug for treating COVID-19, on:

  • How did they build their internal and supplier networks?
  • What was key for meeting volume and time targets?
  • What do they see as new industry best practices for future supplier management?

This program will provide you and your company valuable insights on how you may optimize your supply strategies and practices.

Speakers

  • Remo Colarusso, Vice President, Janssen Supply Chain, Johnson & Johnson
  • Ken Kent, Senior Vice President, Chemical Development and Manufacturing Operations, Gilead Sciences
  • Moderator: Bob KanugaSenior Vice President, Healthcare Logistics and Distribution, UPS Healthcare, Former Vice President, Global Supply Business Development, Merck & Co. Inc., and past DCAT President

Who Should Attend

  • C-suite and senior to mid-level executives of Bio/Pharmaceutical Companies, including those involved in sourcing, procurement, supply management, and manufacturing.
  • C-suite and senior to mid-level executives of CDMOs/CMOs and other suppliers, including those in business development, sales, marketing, and operational functions in support of Bio/Pharmaceutical development and manufacturing.

Pricing and Registration

Online registration for this program is now closed. To register over the phone, please contact Mikaela Venice at 1-609-208-1888 ext. 7015.

The DCAT organization is pleased to offer timely and topical education sessions during DCAT Week. Compared to similar programs found in the industry’s marketplace, our program fees are deeply discounted for employees of DCAT Member Companies. 

Please note: DCAT Week 2021 programs are available to employees of DCAT Member Companies only. Not sure if your company is a DCAT member? Click here or call DCAT at 1-609-208-1888.

  • DCAT Member Company Price: $59.00

Can't make the live webinar? No problem! Registrants will have access to on-demand viewing of the program after the live date until July 31, 2021. Click here to learn more.